Name: WDEC 2020
Start: 2020-07-31
End: 2020-08-02
Location: Scotland

Conference Information

About Conference

2^nd World Congress on Diabetes and Endocrinology is the world’s premiere international educational event will be organized on July 31 - August 01, 2020 at Edinburgh, Scotland. Following the incredible success of World Congress on Diabetes and Endocrinology meeting in Rome, along with encouragement from participants, planning for WDEC 2020 is underway

If you are a diabetologist, cardiologist, endocrinologist, nephrologist, lipidologist, internist, or a clinician with an interest in Diabetes, this meeting is for you!

We cordially welcome you to WDEC 2020 to actively participate in our 2^nd World Congress on Diabetes and Endocrinology, to meet and interact with friends and colleagues from all over the world, to discuss science, to learn about the exciting developments in Diabetes, to break away from the daily routine and to enjoy everything that the city of Edinburgh has to offer.

Take part in the WDEC 2020 and encage yourself in the discussion of Diabetes and Endocrinology with the leading diabetes experts & expand professional networks with colleagues from all over the globe.

“INSPIRING speakers, MOTIVATING workshops, EMPOWERING educational lectures”

A great tasting lunch with the opportunity to connect and make some new friends who totally get you.

The ultimate goal of this Diabetes conference is to discuss about the most effective cutting-edge strategies to help doctors to reach their treatment goals with patients with type 1 diabetes and type 2 diabetes and avoid the associated acute and chronic complications. We promise to infuse some good eats and interesting interaction along the way.

Internationally leading scientists in diabetes and endocrinology research are joining us here in Edinburgh to present and discuss their most recent research and achievements during this event.

Call For Submission

Don't miss this chance to present research on basic science, prevention, and treatment of Diabetes at 2^nd World Congress on Diabetes and Endocrinology in Edinburgh, Scotland on July 31 and August 01, 2020.

It is an opportunity for the young talents to network in a formal setting with the plenary speakers and top scientists in the field.

"Poster and oral slots are available"

Participation in these sessions is upon submission of an abstract (see details below). Applicants will be selected based on the quality of their abstract.

Send us your Abstract through: wdec@pulsusseries.com

For any queries, write to the Conference Committee for better assistance.

Scientific Sessions

Session on: Types of Diabetes and its complications

Over 10% of all people with diabetes have type 1 diabetes. Diabetes will develop at any age, but most frequently occurs in children & adolescents. It is caused by an autoimmune reaction where the body’s defence system attacks the cells that produce insulin. In type 1 diabetes, body produces very little or no insulin, which means that need daily insulin injections to maintain blood glucose levels under control. At present, type 1 diabetes cannot be prevented. Type 2 Diabetes is characterized by insulin resistance, where the body does not fully respond to the insulin. It is because insulin cannot work properly, blood glucose levels will be rising, releasing more insulin. For some people with type 2 diabetes this can exhaust the pancreas, resulting in the body producing less insulin, causing even higher blood sugar levels.

Related conferences: 15^th World Congress on Endocrinology and Diabetes September 20-21, 2019 Prague, Czech Republic; Euro Diabetes Congress and Expo September 20-21, 2019 Prague, Czech Republic; International Congress and Exhibition on Endocrine and Diabetic Complications October 14-15, 2019 Sydney, Australia; 30^th International Conference on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; Annual Congress on Endocrinology, Diabetes and Health Care November 25-26, 2019 Bangkok, Thailand; 28^th International Conference on Diabetes and Endocrinology November 29-30, 2019 Frankfurt, Germany; 3^rd Annual Congress on Diabetes and its Complications December 04-05, 2019 Toyo, Japan; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Pediatric Endocrinology, Diabetes & Metabolism

Endocrine disorders can cause significant medical problems during childhood and adolescence that may have lifelong health and psychological effects. High blood glucose levels with elevated A1C levels are associated with long-term microvascular and macrovascular complications. Recurrent episodes of hypoglycemia, especially at young ages, may cause short- and long-term adverse effects on cognitive function and lead to hypoglycemia unawareness and may be associated with significant emotional morbidity for the child and parents. Development of metabolic complications correlated with obesity during childhood track into adulthood and develop the risk for type 2 diabetes and early cardiovascular disease. Clustering of these metabolic abnormalities, which include insulin resistance, hypertension and dyslipidemia, constitutes the metabolic syndrome, which may affect up to 50% of overweight adolescents. Other serious disorders associated with obesity and insulin resistance include polycystic ovary disease and fatty liver.

Related conferences: 11^th edition of International Conference on Diabetes and Endocrinology September 03-04, 2019 Singapore; World Pediatrics Conference September 16-17, 2019 Paris, France; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; Annual Congress on Diabetes, Metabolism and Obesity November 11-12, 2019 Sydney, Australia; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 14^th European Diabetes and Endocrinology Congress December 02-03, 2019 Barcelona, Spain; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Diabetes and Cancer

Diabetes and cancer are prevalent diseases with high impact on health worldwide. Epidemiologic witness suggests that people with diabetes are at significantly higher risk for many forms of cancer. Type 2 diabetes and cancer share several risk factors, but possible biologic links between the two diseases are incompletely understood. Moreover, witness from observational studies suggests that some medications used to treat hyperglycemia are correlated with either increased or reduced risk of cancer.

Related conferences: 31^st International Conference on Cancer Research and Therapy September 09-10, 2019 Zurich, Switzerland; 15^th World Congress on Endocrinology and Diabetes September 20-21, 2019 Prague, Czech Republic; International Congress and Exhibition on Endocrine and Diabetic Complications October 14-15, 2019 Sydney, Australia; 30^th International Conference on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 28^th International Conference on Diabetes and Endocrinology November 29-30, 2019 Frankfurt, Germany; 3^rd Annual Congress on Diabetes and its Complications December 04-05, 2019 Toyo, Japan; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Diabetes and the kidneys

Kidney disease is far more prevalent in people with diabetes than in people without diabetes. It is caused by damage to small blood vessels, which can cause the kidneys to be less efficient, or to fail altogether. Diabetes is one of the leading causes of chronic kidney disease (CKD). Pooled data from 54 countries declares that more than 80% of cases of end-stage renal disease are caused by diabetes, hypertension or a combination of both. Type 2 diabetes is a leading cause of kidney failure, which is a risk for hypertension, and hypertension can often precede CKD and contribute to the progression of kidney disease. Both diabetes and CKD are strongly correlated with cardiovascular disease (CVD) and therefore, the major component in their management is control of CVD risk factors such as hypertension and high blood glucose. It is important to control blood glucose and blood pressure to reduce the risk of kidney disease.

Related conferences: 11^th edition of International Conference on Diabetes and Endocrinology September 03-04, 2019 Singapore; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; 3^rd International Conference on Diabetes and Metabolism October 14-15, 2019 Rome, Italy; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; Annual Congress on Diabetes, Metabolism and Obesity November 11-12, 2019 Sydney, Australia; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 14^th European Diabetes and Endocrinology Congress December 02-03, 2019 Barcelona, Spain; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Diabetes and Pregnancy

Women who have diabetes before they get pregnant will have special health concerns. In addition, the new demands that a pregnancy will put on your body, it will also affect their blood sugar levels & diabetes medications. High blood sugar levels during the initial stage of the pregnancy can cause birth defects. They also can increase the risks of miscarriage & diabetes-related complications. Some babies are too big to be delivered vaginally, and you'll need a cesarean delivery or c-section.

Session on: The Diabetic Foot problems

Diabetic foot is one of the most prevalent, costly and serious complications of diabetes. Amputation in people with diabetes is 10 to 20 times more common than in people without diabetes and it is estimated that every 30 seconds a lower limb or part of a lower limb is lost somewhere in the world as an effect of diabetes. Diabetic foot can result in a significant economic, social, and public health burden; especially in low-income communities, if there is neither an appropriate educational programme, nor adequate and suitable footwear.

Session on: Cardio Diabetes

Cardiovascular disease is in fact the number one cause of death in patients with type 2 diabetes. Researchers are using the term "cardiodiabetes" to define the co-occurrence of diabetes and significant cardiovascular disease (CVD). There is no absolute predictor of a "cardiovascular event" such as heart attack or stroke, nor is there any 100 percent accurate predictor of CVD, cardiovascular disease.

Related conferences: 7^th World Heart Congress August 19-20, 2019 Vienna, Austria; 7^th World Congress on Hypertension and Public Health September 26-27, 2019 Lisbon, Portugal; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; 3^rd International Conference on Diabetes and Metabolism October 14-15, 2019 Rome, Italy; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; Annual Congress on Diabetes, Metabolism and Obesity November 11-12, 2019 Sydney, Australia; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 14^th European Diabetes and Endocrinology Congress December 02-03, 2019 Barcelona, Spain; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Diabetic retinopathy: Causes, symptoms, and treatments

Diabetic retinopathy destructs the blood vessels within the retinal tissue, causing them to leak fluid and distort vision. Diabetic retinopathy typically starts without any noticeable change in vision. Treating DR depends on many factors, including the severity and type of DR, and how the person with DR has responded to previous treatments. However, patients with diabetes who successfully maintain their blood sugar levels will help to prevent the onset of a severe form of DR.

Related Conferences: 4^th International Conference on Ophthalmology September 19-20, 2019 Osaka, Japan; 7^th World Congress on Hypertension and Public Health September 26-27, 2019 Lisbon, Portugal; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; 3^rd International Conference on Diabetes and Metabolism October 14-15, 2019 Rome, Italy; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; Annual Congress on Diabetes, Metabolism and Obesity November 11-12, 2019 Sydney, Australia; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 14^th European Diabetes and Endocrinology Congress December 02-03, 2019 Barcelona, Spain; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Women in Endocrinology and Diabetes

Diabetes can be hard on women especially. The burden of diabetes on women is unique because of disease can affect both the mothers and unborn babies. Women’s body have two main reproductive hormones, estrogen and progesterone which can affect blood glucose by changing how body reacts to insulin. When estrogen levels are high, cells become more sensitive to insulin. But when estrogen is low and progesterone is high, women will experience insulin resistance, that is, more insulin is required to help cells take in glucose from the blood. Diabetes can cause difficulties during pregnancy like miscarriage, or the baby may bear defects. Women with diabetes are prone heart attack.

Related conferences: 15^th World Congress on Endocrinology and Diabetes September 20-21, 2019 Prague, Czech Republic; International Congress and Exhibition on Endocrine and Diabetic Complications October 14-15, 2019 Sydney, Australia; 30^th International Conference on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 28^th International Conference on Diabetes and Endocrinology November 29-30, 2019 Frankfurt, Germany; 3^rd Annual Congress on Diabetes and its Complications December 04-05, 2019 Toyo, Japan; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Male Reproductive Endocrinology

The endocrine system plays an important role in human reproduction and sexuality. In men, the testes (testicles) produce testosterone. Throughout life, testosterone helps to maintain muscle and bone mass, sperm production, and sex drive. The testes synthesize two important products: testosterone and sperm. The synthesis of both products is monitored by endocrine hormones produced in the hypothalamus and pituitary, as well as locally within the testis. Testosterone is essential for sperm production, however both testosterone and Follicle Stimulating Hormone (FSH) are needed for optimal testicular development and maximal sperm production.

Related conferences: 11^th edition of International Conference on Diabetes and Endocrinology September 03-04, 2019 Singapore; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; Annual Congress on Diabetes, Metabolism and Obesity November 11-12, 2019 Sydney, Australia; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 14^th European Diabetes and Endocrinology Congress December 02-03, 2019 Barcelona, Spain; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Metabolic bone, Calcium and Parathyroid Disorders

Parathyroid disorders lead to anomalous levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems. Hypersecretion of parathyroid gland may lead to brittle bones that fracture easily and stones in the urinary system. Osteoporosis is a skeletal disorder identified by decreased mass and compromised bone strength predisposing to an increased risk of fractures. Secondary osteoporosis can be present in pre- and post-menopausal women and in men. Up to 30% of post-menopausal women and 50–80% of men are found to have factors contributing to osteoporosis when undergoing an evaluation for underlying causes of the disease.

Session on: Adrenal Insufficiency and Adrenal Crisis

Adrenal crisis is a life-threatening exacerbation of adrenal insufficiency due to increased physiologic demand (infection) or decreased supply (discontinuation of steroid therapy) of cortisol. It usually occurs in response to a major stress, such as acute myocardial infarction, sepsis, surgery, major injury, trauma, or other illnesses in any patient with primary or secondary adrenal insufficiency. In this situation, the adrenal gland fails to mount a stress response via increasing circulating cortisol levels. The most frequent iatrogenic cause of acute adrenal crisis is rapid withdrawal of steroids in patients with adrenal atrophy secondary to long-term steroid administration.

Related Conferences: 11^th edition of International Conference on Diabetes and Endocrinology September 03-04, 2019 Singapore; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; Annual Congress on Diabetes, Metabolism and Obesity November 11-12, 2019 Sydney, Australia; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 14^th European Diabetes and Endocrinology Congress December 02-03, 2019 Barcelona, Spain; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Pituitary and Thyroid disorders

Pituitary disorders are mainly due to either too much, or too little secretion of pituitary hormone in the body. These disorders can result in a wide variety of different clinical conditions, depending on which hormone signals are disrupted. Thyroid disorders are conditions that cause serious defects in the thyroid gland. The thyroid has significant roles to regulate numerous metabolic processes throughout the body. Since the thyroid gland is controlled by the pituitary gland and hypothalamus, disorders of these tissues can also affect thyroid function and it will lead to thyroid problems.

Session on: Endocrinology - Obesity and Lipids

Obesity is a prevailing and growing public health problem. Overweight and obesity are the major risk factors for cardiovascular disease. Many cardiovascular disease risk factors are elevated in overweight and obese individuals, including dyslipidemia and inflammation, among others. Adiponectin, a hormone secreted by adipose tissue, has both metabolic and anti-inflammatory properties. Multiple studies have described the relationship between adiponectin and obesity in several human populations. On average, obese women give birth to babies with high fat mass. Placental lipid metabolism alters fetal lipid delivery. LDL Cholesterol plays a prominent role in this "diabetic dyslipidemia" and is considered strongly atherogenic, more a cause than a simple marker of increased risk. The variant known as VLDL, very low-density lipoprotein, seems particularly dangerous--though it appears a rise in HDL, high density lipoprotein cholesterol may moderate its destructive action, even without a corresponding drop in LDL numbers.

Related conferences: 11^th edition of International Conference on Diabetes and Endocrinology September 03-04, 2019 Singapore; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; 10^th Edition of International Obesity and Endocrinology Congress November 11-12, 2019 Barcelona, Spain; International Conference on Obesity and Diet Imbalance November 25-26, 2019 Dubai, UAE; 13^th International Conference on Childhood Obesity and Nutrition March 16-17, 2020 London, UK.

Session on: Neuroendocrine Tumors

A neuroendocrine tumor can grow in spots like your pancreas, a gland in your belly. It can also grow in your stomach, intestines, or lungs. These tumor cells have traits of both hormone-producing endocrine cells and nerve cells. They are found throughout the body’s organs and helps to control many of the body’s functions. Hormones are chemical substances that are carried through the bloodstream to have a distinct effect on the activity of other organs or cells in the body. All NETs are considered as malignant tumors.

Related Conferences: 15^th World Congress on Endocrinology and Diabetes September 20-21, 2019 Prague, Czech Republic; International Congress and Exhibition on Endocrine and Diabetic Complications October 14-15, 2019 Sydney, Australia; 30^th International Conference on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 28^th International Conference on Diabetes and Endocrinology November 29-30, 2019 Frankfurt, Germany; 3^rd Annual Congress on Diabetes and its Complications December 04-05, 2019 Toyo, Japan; Annual Congress on Diabetes and Endocrinology December 12-13,2019 Dubai, UAE.

Session on: Common Challenging Procedures of Diabetes and Endocrinology

Endocrinologists are equipped to treat a range of endocrine disorders and dysfunctions. Limitations in appropriate and timely use of insulin delay the achievement of good glycemic control. Wide-ranging efforts must be made to eliminate negative perception of insulin therapy in the community. Patient and physician targeted programs to increase awareness in different conditions of diabetes care must be commenced across all levels of healthcare ensuring uniformity of information.

Related conferences: 11^th edition of International Conference on Diabetes and Endocrinology September 03-04, 2019 Singapore; International Congress of Diabetes and Metabolism October 10-12, 2019 Seoul, Korea; World Congress on Endocrinology and Metabolic Syndrome October 24-25, 2019 Singapore; 10^th Edition of International Obesity and Endocrinology Congress November 11-12, 2019 Barcelona, Spain; International Conference on Obesity and Diet Imbalance November 25-26, 2019 Dubai, UAE; 13^th International Conference on Childhood Obesity and Nutrition March 16-17, 2020 London, UK.

Session on: Endocrinology Tests and Procedure

Many hormone disorders, such as an underactive thyroid, can be treated with daily hormone medication. Some diseases may require more complex treatment, such as surgery. An endocrinologist can analyse treatment options and help to choose the best one. Blood and urine tests to check your hormone levels can help the doctors to determine about the endocrine disorder. Imaging tests may be done to identify tumor in the body. Treatment of endocrine disorders can be complicated, as a change in one hormone level can deceive another.

Related conferences: International Congress and Exhibition on Endocrine and Diabetic Complications October 14-15, 2019 Sydney, Australia; 30^th International Conference on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 28^th International Conference on Diabetes and Endocrinology November 29-30, 2019 Frankfurt, Germany; 3^rd Annual Congress on Diabetes and its Complications December 04-05, 2019 Toyo, Japan.

Session on: Diabetes Diagnosis and Treatment

Health Care professionals can diagnose diabetes, prediabetes, and gestational diabetes through blood tests. The blood tests show if your blood glucose, also called blood sugar, is too high or low. Some people will not have any direct symptoms but may have some indirect risk factors for diabetes and need to be tested. Testing allows health care professionals to find diabetes sooner and work with their patients to manage diabetes and prevent complications. Doctors usually investigates type 1 diabetes in children and young adults. Because type 1 diabetes can run in families, a study called Trial Net offers free testing to family members of people with the disease, even if they don’t have symptoms. Experts suggests testing children between the ages of 10 and 18 who are overweight or obese and have at least two other risk factors for developing diabetes.

Session on: Diabetes Diet, Eating, & Physical Activity

Healthy eating is the major part of managing diabetes. Eating the right foods and following other lifestyle behaviours that develop healthy blood sugar and insulin levels will give you the best chance at avoiding diabetes. There are a few herbs that may help increase insulin sensitivity and reduce the likelihood of diabetes progression which are curcumin and berberine. The major goal in treating type 1 and type 2 diabetes is to regulate blood sugar (glucose) levels within the normal range. Type 1 diabetes is treated with insulin, exercise, and a healthy diet. Type 2 diabetes is treated with weight reduction, a type 2 diabetes diet, and exercise, diabetes medications (oral or injected) are prescribed when these measures fail to control the elevated blood sugars of type 2 diabetes. If other medications become ineffective treatment with insulin may be initiated.

Related Conferences: International Congress and Exhibition on Endocrine and Diabetic Complications October 14-15, 2019 Sydney, Australia; 30^th International Conference on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; Annual Congress on Endocrinology, Diabetes and Healthcare November 25-26, 2019 Bangkok, Thailand; 28^th International Conference on Diabetes and Endocrinology November 29-30, 2019 Frankfurt, Germany; 3^rd Annual Congress on Diabetes and its Complications December 04-05, 2019 Toyo, Japan.

Registration Benefits

Both individual and group registrations are available

Only Registration Includes:

Access to all scientific program sessions and plenary sessions
Access to exhibition hall and poster viewing area during opening hours
Handbook & Conference Kit
Certificate Accreditation by the International Organizing Committee Members (IOCM)
Abstracts will be published in the conference souvenir and respective international journal
Ask the Expert Forums (One to One Pre-Scheduled meeting on interest and availability)
2 Coffee breaks (refreshments and snacks) during the conference
Lunch during the conference
Our lodging and conference are all under one roof!

"We have secured rooms at the conference venue, with discounted rates"

Why book your accommodation through the conference organisers?

Complimentary Breakfast

Specially negotiated rates

Maximise your networking opportunities

Flexibility to change or cancel your booking at any time up to 30 working days prior to conference start date

To obtain these rates, please book your accommodation by reaching the Conference Secretariat via the online contact form/WhatsApp +44 154 364 8045

Please register today!

Market Analysis

In 2014, the number of people affected by diabetes has increased from 108 million in 1980 to 422 million. The global prevalence of diabetes among adults over 18 years of age has increased from 4.7% to 8.5%. Diabetes occurrence has been increasing more rapidly in middle- and low-income countries. Diabetes is the major cause for blindness, kidney failure, heart attacks, stroke and lower limb amputation. In 2016, estimated 1.6 million deaths were directly caused by diabetes. In 2012, 2.2 million deaths were attributable to high blood glucose. Almost half of all deaths are due to high blood glucose that occur before the age of 70 years. In 2016, WHO evaluates that diabetes was the seventh leading cause of death. Healthy diet, regular physical activity, maintaining a normal body weight and avoiding tobacco use are the major ways to prevent or delay type 2 diabetes. Diabetes can be treated, and its effects can be avoided with proper diet, medication and regular screening of blood glucose levels.

According to the estimates of International Diabetes Federation (IDF), the global prevalence of diabetes is expected to increase day by day. The global diabetes treatment market is going through serious changes driven by the rise of new analytical technologies & developments in diabetes treatments. There has been a drastic increase in occurrence of diabetes among people worldwide, owing to the rising level of sedentary lifestyles and obesity in global population.

The sub-markets like the human insulin and analogues are expected to maintain dominance in the overall diabetes treatment market. The diabetes treatment products are injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems.

In addition, considerable number of emerging diabetes drugs is under clinical observation by many large pharmaceutical companies which are expected to enter the market within the upcoming years. In diabetes treatment, drugs such as januvia & byetta, have shown effective results and good safety. To manage the critical insulin therapy virtually less painful, accurate, easy to use, and improved blood glucose monitoring systems are available in the market. Increase in incidence of type 1 and type 2 diabetes is expected to fuel the diabetes treatment market. In addition, development of type 1 and type 2 diabetes treatments is expected to remain profitable for the pharmaceutical companies in long or short term. An incentive for less wealthy patients specifically in the developing regions, price reductions & stimulate innovation are a few factors promotes the market growth. Owing to the multi-factorial condition of diabetes, drug manufacturers are developing medications for related problems such as kidney disease, strokes, heart disease and obesity, which are evaluating medicines in clinical trials for treating diabetes.

With expanded use of anti-diabetics among people, the manufacturers can offer opportunities to tackle multiple disorders of metabolic diseases, benefiting the healthcare providers & the patients. Furthermore, the medication that target long term weight reduction & other related conditions are in high demand, owing to the cases of type 2 diabetes. There are 7 diabetes treatment submarkets namely, thiazolidinediones, sulphonylureas, meglitinides, DPP-4 inhibitors, biguanides, alpha-glucosidase inhibitors and human insulins and analogues. The diabetic treatment industries are encouraging combinational drug treatments as the monotherapy may lose its existence in the forecast period. Therefore, through technological & commercial progress, the diabetic treatment market has potential for increasing market growth. Major pharmaceutical industries which produces diabetes drugs are Teva Pharmaceuticals Pvt Ltd., Novo Nordisk AS, Merck & Company Inc., Medtronic Inc., Johnson & Johnson, Home Diagnostics Inc., Bayer Healthcare AG, Amylin Pharmaceuticals Inc and Abbott Laboratories.

The market for diabetes care products can be separated as either monitoring/testing products or therapeutics products. Testing products are separated by analyte for glucose, ketones, & microalbumin/albumin. Therapeutic products are separated as insulin, oral hypoglycemic agents & drugs to treat diabetic complications.

Hypoglycemic agents abound and differ in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there are a few rooms for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.

Diabetes continues to be a crucial healthcare problem, fuelling markets for insulin, hypoglycemics and diagnostic products. Uncertainty regarding changes in the U.S. healthcare system, coupled with continued severe cost constraints on global health care systems in general, has sustained this trend. Despite the general down of the economy & healthcare, there have been great progress in the advancement of diabetes treatment & prevention in recent years. New therapeutic products are being suggested regularly & the pipeline is now full of new diabetes therapeutics in development. Never before, in the history of medicine, the outlook for diabetes treatments and preventions are looking so promising.

2^nd World Congress on
Diabetes and Endocrinology (Webinar)

Quick Links

Theme: Getting the essentials right in delivering diabetes treatment & care!